NCT00611247 2018-06-15Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid LeukemiaStanford UniversityPhase 2 Completed42 enrolled 8 charts
NCT00003567 2010-06-11Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaCase Comprehensive Cancer CenterPhase 1 Terminated8 enrolled